centromere protein C pseudogene 1Genealiases: CENPC · CENPC1P1 · CENPC2
Q-omics provides the consensus-scored CENPCP1 profile across patient tissues and cancer cell-line models. CENPCP1 expression is associated with patient survival in 22 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, CENPCP1 is differentially expressed in 5, with the highest sampling consensus in COAD. Additionally, CENPCP1 RNA expression shows 17,182 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight KIRC, COAD, and THYM as cancer lineages where CENPCP1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for CENPCP1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes CENPCP1 survival associations across molecular data types. CENPCP1 RNA expression shows survival associations in the most cancer types (22). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible CENPCP1 RNA expression–survival associations across cancer types. High CENPCP1 expression shows unfavorable associations in SKCM and KIRP, but favorable associations in KIRC, PRAD, MESO and GBM. The KIRC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .001). Together, the overview and detailed table identify KIRC as the clearest survival context for CENPCP1 RNA expression.
This table summarizes CENPCP1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 5. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for CENPCP1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. CENPCP1 shows lower tumor expression in THCA and higher tumor expression in COAD, HNSC, STAD and LIHC. The COAD box plot shows higher CENPCP1 RNA expression in tumor versus normal tissue (log2 FC = +0.064, t-test p = .004).
This table shows molecular features associated with CENPCP1 in patient tissues and cancer cell lines. In patient samples, CENPCP1 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
